---
$id: https://graph.org.ai/products/commodity/51131743
$type: Product
source: UNSPSC
code: "51131743"
title: "Anagrelide hydrochloride monohydrate"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Anagrelide hydrochloride monohydrate

**UNSPSC Code**: 51131743
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the monohydrate form of an antiplatelet agent with the molecular formula C10H7Cl2N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VNS4435G39, chemically known as 6,7-dichloro-1,5-dihydroimidazo(2,1-b)-quinazolin-2(3h)-one monohydrochloride but more generally known as anagrelide hydrochloride, which bears US NIH Compound Identifier 42786. European Medicines Agency schedules Anagrelide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00523MIG. Most nations, for tariff and trade purposes, schedule anagrelide hydrochloride monohydrate under HS 29335995. As of Q4 2014, ANAGRELIDE HYDROCHLORIDE MONOHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(C(C2C1NC3=NC(=O)CN3C2)CL)CL.O.CL.

